The life sciences industry is moving quickly towards decentralised clinical trials and adopting IoT technology in order to improve patient outcomes, ensure accurate data collection, and speed time to market for new therapeutics. The increased interest in mobile devices for connected clinical trials brought with it a surge in demand for electronic patient-reported outcome (ePRO) and electronic clinical outcome assessment (eCOA) platforms.
Clinical Ink, a global clinical technology company, was having such success with their suite of eCOA and ePRO software solutions that they sought the help of a partner to help them scale their business. By partnering with KORE, they were able to develop and deliver a secure, scalable solution to quickly expand their decentralised clinical trials customer base.
Download the case study “Clinical Trials Made Scalable and Secure” to learn how partnering with KORE helped Clinical Ink achieve: